Parkside Financial Bank & Trust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$210K Buy
717
+40
+6% +$13.1K 0.02% 445
2025
Q4
$237K Buy
677
+24
+4% +$8.11K 0.02% 414
2025
Q3
$211K Sell
653
-49
-7% -$15.2K 0.02% 430
2025
Q2
$273K Buy
702
+255
+57% +$103K 0.03% 360
2025
Q1
$189K Buy
447
+46
+11% +$18.5K 0.02% 398
2024
Q4
$148K Sell
401
-89
-18% -$37.2K 0.02% 453
2024
Q3
$255K Sell
490
-10
-2% -$5.34K 0.04% 321
2024
Q2
$271K Buy
500
+44
+10% +$23.3K 0.04% 287
2024
Q1
$236K Buy
456
+88
+24% +$43.8K 0.04% 322
2023
Q4
$174K Sell
368
-26
-7% -$12K 0.03% 344
2023
Q3
$172K Sell
394
-25
-6% -$11.3K 0.04% 290
2023
Q2
$186K Buy
419
+13
+3% +$6K 0.04% 273
2023
Q1
$187K Buy
406
+76
+23% +$36.2K 0.05% 249
2022
Q4
$169K Buy
330
+17
+5% +$8.63K 0.05% 253
2022
Q3
$142K Buy
313
+8
+3% +$3.83K 0.05% 263
2022
Q2
$147K Sell
305
-118
-28% -$58.4K 0.04% 261
2022
Q1
$208K Sell
423
-105
-20% -$48K 0.06% 229
2021
Q4
$245K Sell
528
-24
-4% -$10.1K 0.06% 218
2021
Q3
$206K Buy
552
+53
+11% +$20.1K 0.06% 205
2021
Q2
$191K Buy
499
+11
+2% +$4.2K 0.06% 216
2021
Q1
$175K Buy
488
+5
+1% +$1.61K 0.05% 221
2020
Q4
$155K Buy
483
+28
+6% +$8.59K 0.05% 237
2020
Q3
$123K Sell
455
-34
-7% -$9.15K 0.04% 252
2020
Q2
$128K Sell
489
-16
-3% -$4.27K 0.04% 256
2020
Q1
$114K Sell
505
-7
-1% -$1.91K 0.04% 228
2019
Q4
$155K Sell
512
-75
-13% -$20.6K 0.05% 223
2019
Q3
$141K Sell
587
-5
-0.8% -$1.37K 0.05% 219
2019
Q2
$167K Buy
592
+11
+2% +$3K 0.05% 207
2019
Q1
$166K Buy
581
+75
+15% +$21.7K 0.06% 199
2018
Q4
$133K Buy
506
+20
+4% +$5.5K 0.05% 214
2018
Q3
$133K Sell
486
-13
-3% -$3.38K 0.05% 215
2018
Q2
$119K Sell
499
-165
-25% -$38.2K 0.04% 217
2018
Q1
$145K Buy
664
+11
+2% +$2.58K 0.06% 194
2017
Q4
$147K Buy
653
+186
+40% +$39.6K 0.05% 192
2017
Q3
$88K Hold
467
0.03% 243
2017
Q2
$88K Sell
467
-15
-3% -$2.69K 0.04% 224
2017
Q1
$80K Buy
482
+402
+503% +$63.9K 0.03% 239
2016
Q4
$12K Buy
80
+46
+135% +$6.16K 0.01% 652
2016
Q3
$4K Buy
34
+18
+113% +$2.32K ﹤0.01% 878
2016
Q2
$2K Sell
16
-22
-58% -$3.01K ﹤0.01% 920
2016
Q1
$5K Sell
38
-37
-49% -$4.94K ﹤0.01% 771
2015
Q4
$10K Buy
75
+15
+25% +$2.07K 0.01% 653
2015
Q3
$8K Buy
+60
New +$9.02K ﹤0.01% 687

Other funds holding ELV

Parkside Financial Bank & Trust's ELV Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Elevance Health (ELV) stake by 5.9% in Q1 2026, buying an estimated $13.1K and bringing the position to 717 shares worth $210K. The position accounts for 0.02% of the portfolio, ranked #445.

Parkside Financial Bank & Trust first reported a position in ELV in Q3 2015 and has held it in 43 quarters since. The position peaked at $273K in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Parkside Financial Bank & Trust held 717 shares of Elevance Health worth $210K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 40 Elevance Health shares in Q1 2026, an estimated $13.1K.
  • Elevance Health made up 0.02% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #445 holding.
  • Parkside Financial Bank & Trust first reported a position in Elevance Health in Q3 2015 and has held it in 43 quarters since.
  • Parkside Financial Bank & Trust's Elevance Health position peaked at $273K in Q2 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.